CPT code 64625 represents radiofrequency ablation of the nerves supplying the sacroiliac joint, a minimally invasive procedure that uses focused radio waves to thermally destroy nerve tissue and reduce chronic sacroiliac joint pain. Nationally, this code is important as utilization of interventional pain procedures grows with the aging population and the emphasis on non-opioid pain management strategies.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of clinical context for sacroiliac joint denervation, typical sites of service, and what to expect in payer coverage considerations. The publication outlines benchmarks and policy-relevant topics such as utilization patterns, coding and documentation priorities, and factors that influence coverage decisions.

The report is designed to help billing managers, clinicians in pain management, and health policy professionals understand where CPT code 64625 fits in clinical practice and payer policy. It highlights clinical indications, service delivery settings, and operational considerations that affect reimbursement and access. Data not available in the input will be flagged as such in specific sections.